Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1264

1.

Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer.

Abu-Gheida I, Reddy CA, Kotecha R, Weller MA, Shah C, Kupelian PA, Mian O, Ciezki JP, Stephans KL, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2019 Feb 2. pii: S0360-3016(19)30182-8. doi: 10.1016/j.ijrobp.2019.01.091. [Epub ahead of print]

PMID:
30721720
2.

The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility, and a revised proposal.

Le Rhun E, Devos P, Boulanger T, Smits M, Brandsma D, Rudà R, Furtner J, Hempel JM, Postma TJ, Roth P, Snijders TJ, Winkler F, Winklerhofer S, Castellano A, Hattingen E, Capellades J, Gorlia T, van den Bent M, Wen PY, Bendzus M, Weller M; European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group (BTG) Central Nervous System (CNS) Metastases Committee and the EORTC BTG Imaging Committee.

Neuro Oncol. 2019 Jan 23. doi: 10.1093/neuonc/noz024. [Epub ahead of print]

PMID:
30715514
3.

Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications.

Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junk L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Rudà R, Weller M, van den Bent MJ, Vogelbaum MA, Chang S, Wen PY, Soffietti R.

Neuro Oncol. 2019 Jan 22. doi: 10.1093/neuonc/noz012. [Epub ahead of print]

PMID:
30668804
4.

PET Imaging in Patients with Brain Metastasis - Report of the RANO/PET Group.

Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC.

Neuro Oncol. 2019 Jan 5. doi: 10.1093/neuonc/noz003. [Epub ahead of print]

PMID:
30615138
5.

Breakdown of the Spectator Concept in Low-Electron-Energy Resonant Decay Processes.

Mhamdi A, Rist J, Aslitürk D, Weller M, Melzer N, Trabert D, Kircher M, Vela-Pérez I, Siebert J, Eckart S, Grundmann S, Kastirke G, Waitz M, Khan A, Schöffler MS, Trinter F, Dörner R, Jahnke T, Demekhin PV.

Phys Rev Lett. 2018 Dec 14;121(24):243002. doi: 10.1103/PhysRevLett.121.243002.

PMID:
30608769
6.

RNA sequencing differential gene expression analysis of isolated perfused bovine udders experimentally inoculated with Streptococcus agalactiae.

Sbardella AP, Weller MMDCA, Fonseca I, Stafuzza NB, Bernardes PA, E Silva FF, da Silva MVGB, Martins MF, Munari DP.

J Dairy Sci. 2019 Feb;102(2):1761-1767. doi: 10.3168/jds.2018-15516. Epub 2018 Dec 26.

PMID:
30594374
7.

Closed-loop cavitation control for focused ultrasound-mediated blood-brain barrier opening by long-circulating microbubbles.

Çavuşoğlu M, Zhang J, Ielacqua GD, Pellegrini G, Signorell RD, Papachristodoulou A, Brambilla D, Roth P, Weller M, Rudin M, Martin E, Leroux JC, Werner B.

Phys Med Biol. 2019 Feb 11;64(4):045012. doi: 10.1088/1361-6560/aafaa5.

PMID:
30577029
8.

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.

Seoane J, De Mattos-Arruda L, Le Rhun E, Bardelli A, Weller M.

Ann Oncol. 2018 Dec 21. doi: 10.1093/annonc/mdy544. [Epub ahead of print]

PMID:
30576421
9.

Beyond the headlines: Fetal movement awareness is an important stillbirth prevention strategy.

Flenady V, Ellwood D, Bradford B, Coory M, Middleton P, Gardener G, Radestad I, Homer C, Davies-Tuck M, Forster D, Gordon A, Groom K, Crowther C, Walker S, Foord C, Warland J, Murphy M, Said J, Boyle F, O'Donoghue K, Cronin R, Sexton J, Weller M, McCowan L.

Women Birth. 2019 Feb;32(1):1-2. doi: 10.1016/j.wombi.2018.12.001. Epub 2018 Dec 15. No abstract available.

PMID:
30563769
10.

Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.

Le Rhun E, von Achenbach C, Lohmann B, Silginer M, Schneider H, Meetze K, Szabo E, Weller M.

Int J Cancer. 2018 Dec 14. doi: 10.1002/ijc.32069. [Epub ahead of print]

PMID:
30549269
11.

MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis, and response to cytotoxic therapy.

Krell A, Wolter M, Stojcheva N, Hertler C, Liesenberg F, Zapatka M, Weller M, Malzkorn B, Reifenberger G.

Neuropathol Appl Neurobiol. 2018 Dec 13. doi: 10.1111/nan.12532. [Epub ahead of print]

PMID:
30548945
12.

Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes.

Papachristodoulou A, Signorell RD, Werner B, Brambilla D, Luciani P, Cavusoglu M, Grandjean J, Silginer M, Rudin M, Martin E, Weller M, Roth P, Leroux JC.

J Control Release. 2019 Feb 10;295:130-139. doi: 10.1016/j.jconrel.2018.12.009. Epub 2018 Dec 8.

PMID:
30537486
13.

Mobile Workflow in Computed Tomography of the Chest.

Wetzl M, Weller M, Heiss R, Schrüfer E, Wuest W, Thierfelder C, Lerch D, Cavallaro A, Amarteifio P, Uder M, May MS.

J Med Syst. 2018 Dec 10;43(1):14. doi: 10.1007/s10916-018-1131-2.

14.

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.

Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.

15.

Pseudoprogression: fact or wishful thinking in neuro-oncology?

Reardon DA, Weller M.

Lancet Oncol. 2018 Dec;19(12):1561-1563. doi: 10.1016/S1470-2045(18)30654-5. No abstract available.

PMID:
30507413
16.

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.

Hegi ME, Genbrugge E, Gorlia T, Stupp R, Gilbert MR, Chinot OL, Nabors LB, Jones G, Van Criekinge W, Straub J, Weller M.

Clin Cancer Res. 2018 Dec 4. doi: 10.1158/1078-0432.CCR-18-3181. [Epub ahead of print]

PMID:
30514777
17.

Digging into the Sequential Space of Thiolactone Precision Polymers: A Combinatorial Strategy to Identify Functional Domains.

Celasun S, Remmler D, Schwaar T, Weller MG, Du Prez F, Börner HG.

Angew Chem Int Ed Engl. 2019 Feb 11;58(7):1960-1964. doi: 10.1002/anie.201810393. Epub 2019 Jan 17.

PMID:
30452103
18.

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p.

Sievers P, Stichel D, Hielscher T, Schrimpf D, Reinhardt A, Wefers AK, Reuss D, Jones DTW, Bewerunge-Hudler M, Hartmann C, Baumgarten P, Wirsching HG, Winther-Kristensen B, Brokinkel B, Ketter R, Idoate Gastearena MA, Lamszus K, Seiz-Rosenhagen M, Mawrin C, Harter PN, Felsberg J, Hänggi D, Herold-Mende C, Berghoff AS, Weller M, Pfister SM, Wick W, Reifenberger G, Preusser M, von Deimling A, Sahm F.

Acta Neuropathol. 2018 Dec;136(6):975-978. doi: 10.1007/s00401-018-1924-x. Epub 2018 Oct 31. No abstract available.

PMID:
30382370
19.

Cognitive Aids for the Diagnosis and Treatment of Neuroanesthetic Emergencies: Consensus Guidelines on Behalf of the Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Education Committee.

Hoefnagel AL, Rajan S, Martin A, Mahendra V, Knutson AK, Uejima JL, Kositratna G, Weller M, Yang H, Ahuja S, Bailey C, Bebawy JF.

J Neurosurg Anesthesiol. 2019 Jan;31(1):7-17. doi: 10.1097/ANA.0000000000000551.

PMID:
30334936
20.

Contraceptive drugs mitigate experimental stroke-induced brain injury.

El Amki M, Binder N, Steffen R, Schneider H, Luft AR, Weller M, Imthurn B, Merki-Feld GS, Wegener S.

Cardiovasc Res. 2018 Oct 5. doi: 10.1093/cvr/cvy248. [Epub ahead of print]

PMID:
30295757
21.

Women's knowledge about risk factors of breast cancer in a Brazilian community.

Freitas ÂGQ, Weller M.

Women Health. 2018 Oct 4:1-11. doi: 10.1080/03630242.2018.1516266. [Epub ahead of print]

PMID:
30285565
22.

Points & Pearls: Diagnosing and managing common genital emergencies in pediatric girls

Arzubi-Hughes MK, Salts LA, Weller MA, Wilson B.

Pediatr Emerg Med Pract. 2018 Oct 1;15(Suppl 10):1-2.

PMID:
30280870
23.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M.

Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26. No abstract available.

PMID:
30259105
24.

Diagnosing and managing common genital emergencies in pediatric girls.

Arzubi-Hughes MK, Salts LA, Weller MA.

Pediatr Emerg Med Pract. 2018 Oct;15(10):1-23. Epub 2018 Oct 1.

PMID:
30251816
25.

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.

Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, Schormann C, Poeschel V, Ziepert M, Walter S, Roth P, Weller M, Szczepanowski M, Klapper W, Monoranu C, Rosenwald A, Möller P, Hartmann S, Hansmann ML, Mackensen A, Schäfer H, Schorb E, Illerhaus G, Buslei R, Bohle RM, Stilgenbauer S, Kim YJ, Pfreundschuh M.

Blood. 2018 Dec 27;132(26):2744-2753. doi: 10.1182/blood-2018-03-836932. Epub 2018 Sep 24.

PMID:
30249786
26.

Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients.

Wirsching HG, Richter JK, Sahm F, Morel C, Krayenbuehl N, Rushing EJ, von Deimling A, Valavanis A, Weller M.

J Neurooncol. 2018 Dec;140(3):659-667. doi: 10.1007/s11060-018-2996-0. Epub 2018 Sep 8.

PMID:
30196368
27.

Pre- and post-puberty expression of genes and proteins in the uterus of Bos indicus heifers: the luteal phase effect post-puberty.

Fortes MRS, Zacchi LF, Nguyen LT, Raidan F, Weller MMDCA, Choo JJY, Reverter A, Rego JPA, Boe-Hansen GB, Porto-Neto LR, Lehnert SA, Cánovas A, Schulz BL, Islas-Trejo A, Medrano JF, Thomas MG, Moore SS.

Anim Genet. 2018 Dec;49(6):539-549. doi: 10.1111/age.12721. Epub 2018 Sep 7.

PMID:
30192028
28.

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.

Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M, Reifenberger G, Weller M, Hänggi D, Wick W, Herold-Mende C, Westphal M, Brandner S, Pfister SM, Capper D, Sahm F, von Deimling A.

Acta Neuropathol. 2018 Nov;136(5):793-803. doi: 10.1007/s00401-018-1905-0. Epub 2018 Sep 5.

PMID:
30187121
29.

Predicting responsiveness to fampridine in gait-impaired patients with multiple sclerosis.

Filli L, Werner J, Beyer G, Reuter K, Petersen JA, Weller M, Zörner B, Linnebank M.

Eur J Neurol. 2019 Feb;26(2):281-289. doi: 10.1111/ene.13805. Epub 2018 Oct 7.

PMID:
30171655
30.

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.

Huang RY, Bi WL, Weller M, Kaley T, Blakeley J, Dunn I, Galanis E, Preusser M, McDermott M, Rogers L, Raizer J, Schiff D, Soffietti R, Tonn JC, Vogelbaum M, Weber D, Reardon DA, Wen PY.

Neuro Oncol. 2019 Jan 1;21(1):26-36. doi: 10.1093/neuonc/noy137.

PMID:
30137421
31.

The Object Orientation Effect in Exocentric Distances.

Weller M, Takahashi K, Watanabe K, Bülthoff HH, Meilinger T.

Front Psychol. 2018 Aug 3;9:1374. doi: 10.3389/fpsyg.2018.01374. eCollection 2018.

32.

Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.

Jenkinson MD, Weber DC, Haylock BJ, Sherratt FC, Young B, Weller M, Bulbeck H, Culeddu G, Hughes DA, Brain A, Das K, Preusser M, Francis P, Gamble C.

J Neurosurg. 2018 Oct;129(4):1104-1105. doi: 10.3171/2018.6.JNS181418. Epub 2018 Aug 17. No abstract available.

33.

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

van den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ, Clement P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis J, Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C, Golfinopoulos V, Gorlia T, Idbaih A.

Lancet Oncol. 2018 Sep;19(9):1170-1179. doi: 10.1016/S1470-2045(18)30362-0. Epub 2018 Aug 13.

PMID:
30115593
34.

Response Assessment of Meningioma: 1D, 2D and Volumetric Criteria for Treatment Response and Tumor Progression.

Huang RY, Unadkat P, Linda Bi W, George E, Preusser M, McCracken DJ, Keen JR, Read WL, Olson JJ, Seystahl K, Le Rhun E, Roelcke U, Koeppen S, Furtner J, Weller M, Raizer JJ, Schiff D, Wen PY.

Neuro Oncol. 2018 Aug 2. doi: 10.1093/neuonc/noy126. [Epub ahead of print]

PMID:
30085283
35.

A tissue-based draft map of the murine MHC class I immunopeptidome.

Schuster H, Shao W, Weiss T, Pedrioli PGA, Roth P, Weller M, Campbell DS, Deutsch EW, Moritz RL, Planz O, Rammensee HG, Aebersold R, Caron E.

Sci Data. 2018 Aug 7;5:180157. doi: 10.1038/sdata.2018.157.

36.

Resonance signatures in the body-frame valence photoionization of CF4.

Larsen KA, Trevisan CS, Lucchese RR, Heck S, Iskandar W, Champenois E, Gatton A, Moshammer R, Strom R, Severt T, Jochim B, Reedy D, Weller M, Landers AL, Williams JB, Ben-Itzhak I, Dörner R, Slaughter D, McCurdy CW, Weber T, Rescigno TN.

Phys Chem Chem Phys. 2018 Aug 15;20(32):21075-21084. doi: 10.1039/c8cp03637c.

37.

Investigations of the Copper Peptide Hepcidin-25 by LC-MS/MS and NMR.

Abbas IM, Vranic M, Hoffmann H, El-Khatib AH, Montes-Bayón M, Möller HM, Weller MG.

Int J Mol Sci. 2018 Aug 2;19(8). pii: E2271. doi: 10.3390/ijms19082271.

38.

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, Löffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, Reifenberger G, Pfister SM, Tonn JC, Weller M; German Glioma Network.

Neuro Oncol. 2018 Nov 12;20(12):1616-1624. doi: 10.1093/neuonc/noy118.

PMID:
30053291
39.

Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.

Le Rhun E, Genbrugge E, Stupp R, Chinot OL, Nabors LB, Cloughesy T, Reardon DA, Wick W, Gorlia T, Weller M.

Eur J Cancer. 2018 Sep;101:95-104. doi: 10.1016/j.ejca.2018.06.029. Epub 2018 Jul 20.

PMID:
30036741
40.

Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

Lefranc F, Le Rhun E, Kiss R, Weller M.

Cancer Treat Rev. 2018 Jul;68:145-154. doi: 10.1016/j.ctrv.2018.06.017. Epub 2018 Jun 26. Review.

41.

Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

Jelcic I, Hanson JVM, Lukas S, Weber KP, Landau K, Pless M, Reindl M, Weller M, Martin R, Lutterotti A, Schippling S.

J Neuroophthalmol. 2019 Mar;39(1):3-7. doi: 10.1097/WNO.0000000000000669.

PMID:
30015656
42.

Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.

Binder ZA, Thorne AH, Bakas S, Wileyto EP, Bilello M, Akbari H, Rathore S, Ha SM, Zhang L, Ferguson CJ, Dahiya S, Bi WL, Reardon DA, Idbaih A, Felsberg J, Hentschel B, Weller M, Bagley SJ, Morrissette JJD, Nasrallah MP, Ma J, Zanca C, Scott AM, Orellana L, Davatzikos C, Furnari FB, O'Rourke DM.

Cancer Cell. 2018 Jul 9;34(1):163-177.e7. doi: 10.1016/j.ccell.2018.06.006.

PMID:
29990498
43.

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.

Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, Berghoff AS, Marsh K, Steadman M, Zhu D, Nicolay B, Wiestler B, Breckwoldt MO, Al-Ali R, Karcher-Bausch S, Bozza M, Oezen I, Kramer M, Meyer J, Habel A, Eisel J, Poschet G, Weller M, Preusser M, Nadji-Ohl M, Thon N, Burger MC, Harter PN, Ratliff M, Harbottle R, Benner A, Schrimpf D, Okun J, Herold-Mende C, Turcan S, Kaulfuss S, Hess-Stumpp H, Bieback K, Cahill DP, Plate KH, Hänggi D, Dorsch M, Suvà ML, Niemeyer BA, von Deimling A, Wick W, Platten M.

Nat Med. 2018 Aug;24(8):1192-1203. doi: 10.1038/s41591-018-0095-6. Epub 2018 Jul 9.

PMID:
29988124
44.

Copy number profiling across glioblastoma populations has implications for clinical trial design.

Cimino PJ, McFerrin L, Wirsching HG, Arora S, Bolouri H, Rabadan R, Weller M, Holland EC.

Neuro Oncol. 2018 Sep 3;20(10):1368-1373. doi: 10.1093/neuonc/noy108.

PMID:
29982740
45.

On the way to precision formulation additives: 2D-screening to select solubilizers with tailored host and release capabilities.

Remmler D, Schwaar T, Pickhardt M, Donth C, Mandelkow E, Weller MG, Börner HG.

J Control Release. 2018 Sep 10;285:96-105. doi: 10.1016/j.jconrel.2018.06.032. Epub 2018 Jun 28.

PMID:
29964137
46.

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.

Valko PO, Roschitzki B, Faigle W, Grossmann J, Panse C, Biro P, Dambach M, Spahn DR, Weller M, Martin R, Baumann CR.

J Sleep Res. 2018 Jul 1:e12721. doi: 10.1111/jsr.12721. [Epub ahead of print]

PMID:
29961995
47.

Corrigendum: Computer-assisted quantification of motile and invasive capabilities of cancer cells.

Kumar KS, Pillong M, Kunze J, Burghardt I, Weller M, Grotzer MA, Schneider G, Baumgartner M.

Sci Rep. 2018 Jul 2;8:46996. doi: 10.1038/srep46996.

48.

Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.

von Achenbach C, Weller M, Szabo E.

J Neurochem. 2018 Oct;147(1):99-109. doi: 10.1111/jnc.14538. Epub 2018 Aug 16.

PMID:
29953622
49.

Tumor-treating fields: time for demystification.

Weller M.

Ann Oncol. 2018 Aug 1;29(8):1628-1630. doi: 10.1093/annonc/mdy220. No abstract available.

PMID:
29905756
50.

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY.

Neuro Oncol. 2018 Jun 18;20(7):897-906. doi: 10.1093/neuonc/noy056.

PMID:
29788429

Supplemental Content

Loading ...
Support Center